Neuropsychiatric disturbances represent some of the most challenging manifestations encountered in neurodegenerative medicine. In patients with prodromal Lewy body dementia, behavioral and affective changes often precede overt cognitive and motor decline by several years. These early symptoms impose significant distress on patients and elevate caregiver burden considerably. Historically, clinicians viewed these manifestations as reactive emotional responses to progressive physical debility. However, modern functional neuroimaging demonstrates that intrinsic network breakdown drives these complex behavioral phenotypes. Understanding these neural substrates allows clinicians to identify vulnerable individuals earlier, optimize diagnostic precision, and guide therapeutic strategies before irreversible neurodegeneration occurs.

Defining Neuropsychiatric Phenotypes in Prodromal Lewy Body Dementia

The prodromal phase of Lewy body disease encompasses mild cognitive impairment with Lewy bodies and Parkinson's disease mild cognitive impairment. Clinicians frequently observe that neuropsychiatric symptoms emerge early across both entities. However, their presentation often varies widely in clinical practice. To understand these variations, investigators utilize structured assessments like the Neuropsychiatric Inventory alongside data reduction techniques. Principal component analyses consistently isolate three discrete symptom factors: affective disturbances, psychotic manifestations, and anxiety. Affective features typically present as persistent apathy and clinical depression. In contrast, psychosis manifests primarily through recurrent visual hallucinations and persecutory delusions. Furthermore, anxiety frequently emerges as heightened autonomic arousal and generalized distress. Consequently, segregating these clinical dimensions enables targeted neuroimaging investigations into network alterations.

Resting-State Network Breakdown Across Functional Brain Hubs

Resting-state functional magnetic resonance imaging provides non-invasive insight into large-scale functional architecture. Investigators evaluate five primary networks: default mode, limbic, salience, visual, and dorsal attention networks. Each circuit modulates specific domains of cognition, emotional appraisal, and sensory processing. In healthy individuals, these networks maintain precise coordination through synchronized low-frequency fluctuations. Conversely, alpha-synuclein pathology disrupts this synchronization across cortical and subcortical nodes. Seed-to-voxel connectivity analyses demonstrate that affective symptoms link directly to altered coupling between the limbic orbitofrontal cortex and default mode hubs. These regions include the medial prefrontal cortex, subgenual cingulate, and precuneus. Consequently, pathological hyperconnectivity within these self-referential circuits promotes rumination and depressive states in vulnerable patients.

Distinct Circuit Alterations Across Prodromal Subtypes

Neuroimaging evaluations reveal intriguing differences between Parkinson's disease mild cognitive impairment and mild cognitive impairment with Lewy bodies. In Parkinson's cohorts, affective and anxiety scores correlate strongly with aberrant frontolimbic connectivity. Specifically, patients display heightened connectivity between the limbic orbitofrontal cortex and default mode structures. Simultaneously, they exhibit weakened connectivity between the orbitofrontal cortex and the brainstem monoaminergic centers. In addition, these patients demonstrate reduced coupling between the salience network and the medial prefrontal cortex. These divergent patterns underscore an inability to regulate emotional salience effectively. In contrast, mild cognitive impairment with Lewy bodies features early disruptions in frontoparietal and attentional networks. Therefore, while both conditions share synuclein pathology, their distinct network vulnerabilities dictate clinical symptom expression.

Diagnostic Value of Functional Neuroimaging in Clinical Practice

Differentiating prodromal Lewy body disorders from early Alzheimer's disease or primary psychiatric illness presents a significant diagnostic hurdle. Patients presenting with late-onset depression, visual illusions, or unexplained apathy frequently undergo prolonged diagnostic workups. Structural imaging often shows non-specific age-related changes or mild cortical atrophy. In contrast, resting-state functional connectivity reveals profound physiological abnormalities before structural loss appears. By mapping dysconnectivity across salience, limbic, and default mode networks, clinicians can corroborate suspected Lewy body pathology objectively. Furthermore, these imaging biomarkers help differentiate primary affective disorders from neurodegenerative syndromes. Therefore, integrating resting-state functional neuroimaging into clinical workflows enhances diagnostic confidence and reduces misdiagnosis rates.

Implications for Targeted Neuropsychiatric Interventions

Delineating specific network disruptions directly informs therapeutic strategies for managing behavioral symptoms. Pharmacological interventions in Lewy body disorders demand exceptional caution due to profound neuroleptic sensitivity and fluctuating cognition. Typical antipsychotics carry life-threatening risks, whereas certain antidepressants may exacerbate autonomic dysfunction or insomnia. Fortunately, identifying frontolimbic dysconnectivity provides compelling rationale for non-pharmacological neuromodulation strategies. For example, repetitive transcranial magnetic stimulation targeting prefrontal nodes can normalize aberrantly connected default mode circuits. In addition, cholinesterase inhibitors demonstrate efficacy by improving network stability across attentional and salience hubs. Ultimately, pairing network-level biomarkers with tailored neurochemical and behavioral therapies offers clinicians powerful tools to improve long-term functional outcomes.

What is prodromal Lewy body dementia?

Prodromal Lewy body dementia represents the earliest symptomatic stage preceding full dementia. Patients exhibit mild cognitive impairment alongside core features such as REM sleep behavior disorder, motor parkinsonism, cognitive fluctuations, or neuropsychiatric disturbances, without experiencing severe disruption to their basic activities of daily living.

Which brain networks are most disrupted by neuropsychiatric symptoms?

Affective and psychotic symptoms in this population primarily disrupt the default mode network, limbic network, and salience network. Pathological connectivity between the limbic orbitofrontal cortex and prefrontal regions impairs emotional appraisal, while altered salience network integration impairs the appropriate processing of internal and external stimuli.

How does neuroimaging distinguish prodromal Lewy body disease from depression?

Functional neuroimaging reveals distinct dysconnectivity between frontolimbic hubs, default mode nodes, and brainstem monoaminergic pathways that does not occur in primary late-life psychiatric depression. These objective biomarkers help clinicians differentiate early neurodegenerative pathology from primary affective disorders effectively.

Disclaimer: This content is for informational and educational purposes only. It is not intended to substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions you may have regarding a medical condition. Clinical decisions must remain individualized and guided by local regulatory approvals, clinical guidelines, and patient circumstances. Refer to the latest local and national guidelines for clinical practice.

References

Wright LM et al. Brain network connectivity underlying neuropsychiatric symptoms in prodromal Lewy body dementia. Neurobiol Aging. 2025 Jul. doi: 10.1016/j.neurobiolaging.2025.04.007. PMID: 40267731.

McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88-100.

Taylor JP, McKeith IG, Burn DJ, et al. New dimensions in the diagnosis and management of dementia with Lewy bodies. Lancet Neurol. 2020;19(2):159-173.

Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7(1):47.